Logo

Health Equity in Uncertain Times

Share Your Story
Brittany Charlton's avatar

Grateful to Katie Wu at The Atlantic for being responsive, thorough, and reflective when I asked if she'd tackle this story. In the hours since publication, however, our work has entirely changed... I originally felt compelled to speak out in a climate where fear stifles many voices. As Katie quoted me saying, none of my grants had been terminated at the time of our last interview. While I had a lot to lose, this story had to come to light—not just for the LGBTQ community, but for all Americans. However, I just received a "termination" letter for one of my large-scale NIH grants. Our research is now halted on revealing how discriminatory laws (e.g., 'Don't Say Gay' bills) lead to depression and suicide among LGBTQ teens. This "termination" letter is unprecedented as NIH grants are reviewed and approved in a highly competitive grant process and rarely are forced to stop. But now our grants are being terminated solely because the work is "in conflict" with various executive orders (e.g., “gender ideology,” DEI). LGBTQ health is not an obscure, fringe, or ideological issue. The latest data show that 1 in 10 Americans identify as LGBTQ and the number is twice as high among young people. We’re not trying to advance any radical ideology. We’re scientists, trying to keep people healthy. This should be a goal that everyone can get behind. And it is frightening to see our research being cancelled without cause. Our science shows political rhetoric targeting the LGBTQ community causes real, painful harms. Talk isn’t “just” talk — it causes devastating health impacts. Having our NIH-funded research halted is a double whammy. It’s not just that the administration is shutting down research designed to improve health. They are also harming health with rhetoric that seeks to erase our entire community from existence. We desperately need foundations and individual philanthropists to sustain our research. Many of our studies have been ongoing for decades and are in jeopardy of being permanently destroyed. And at the same time, while we need philanthropy, it cannot entirely fill the gap. The NIH is the world's largest funder of biomedical research; it must continue to fund a broad range of rigorous science to improve health and well-being for every member of our society. Read the full piece 👇 lnkd.in/ec3Yb2AU

- Brittany Charlton
Carrie Wolinetz's avatar

The U.S. Department of Health and Human Services (HHS) has publicly posted a list of awards that have been terminated: lnkd.in/eu3zNmVE (Found linked on this page: taggs.hhs.gov/) In addition to recommending the excellent article in The Atlantic by Katherine J. Wu on the havoc wreaked by this unprecedented and abrupt cessation of funding (lnkd.in/ewKSZ-Fx), I think everyone should take a moment to reflect on what our country is choosing to end (and note this is an incomplete list, so the damage is far greater). Grants on #Alzheimers Disease. Awards to understand why men and women have different responses to therapy for #kidney disease. Training programs for young scientists. A center award to accelerate translational research so that treatments get to patients faster. An award focused on education to prevent zoonotic diseases, like bird flu. This is the ending medical research in more than two dozen states, red and blue: Alabama; Arizona; California; Colorado; Connecticut; DC; Florida; Georgia; Illinois; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Montana; Nebraska; Nevada; New York; North Carolina; Ohio; Pennsylvania; Rhode Island; South Carolina; Tennessee; Texas; Vermont; and Washington. For those states, this means people are losing jobs, patients are losing the opportunity to participate in clinical studies near their homes, and the economic activity associated with research funded by The National Institutes of Health has been lost. Priorities change with Administrations. There are ways to reprogram money to align with new priorities, instead of terminating. Finding treatments to terminal diseases should be a higher priority than accelerating processes to terminal awards.

- Carrie Wolinetz
Danielle B.'s avatar

My favorite thing for today, the day after many NIH study sections were abruptly cancelled: the study of public administration, specifically, the work of Dr. Don Kettl, who wrote my favorite book, The Transformation of Governance. Dr. Kettl's writing has a spirit of creativity, practicality, and bridge building that we desperately need right now. Public administration and management is a field of study, with scientists who research what works and what doesn't. You don't just throw ideas at the ceiling and see what sticks. There is an evidence base for best practices. There are reasons that things are set up the way that they are, with researchers (and public administrators) constantly trying to improve these systems for maximum public benefit. I often joke that I got my doctorate in public administration because you need a PhD in bureaucracy to raise a child with disabilities. It seems that we also need a PhD in bureaucracy to do science. Yesterday was a sad and difficult day with the chaos and confusion around the grant reviews, but as someone who has watched a child have seizures nearly every day for 14+ years, I can tell you that we are tougher than we know. In the words of the great Florynce Kennedy (look her up): "Don't agonize, organize!" We can't spiral. We must dust ourselves off and keep going. Patient advocates are very good at organizing and telling our stories, especially the stories about the need for research into our diseases. It is once again time for us to lead. It is not fair but I don't have to tell you that life is unfair. In the coming days I will post about ways to support our colleagues in government and academic research, so that we can continue our good, DIVERSE, EQUITABLE, AND INCLUSIVE work together. I welcome the advice of experts in my network and hope to create a positive place for brainstorming and information. The first thing we can do is simple: check in with our colleagues and let them know that we support them.

- Danielle B.
Abby Kroken's avatar

I’m grateful that the WLC magazine included an article about me, highlighting the 1.9M NIH grant I received. However, I’m uncertain if that figure will remain accurate, and what current changes to science funding mean for me as a newer independent scientist, and for the futures of the trainees in my lab. I have nothing but gratitude for the education, support, and encouragement I got from WLC, especially as a first generation college student. I was still figuring out what sorts of things excited me the most, and which career options might let me do more of those activities. I would have never guessed that being a professor and a scientist was in my future, but my mentors showed me what was possible at each step of my training—at WLC, MCW, and UC Berkeley. As a result, I’m passionate about places that support first gen students and scientists, and every day I’m grateful that I landed at Loyola University Chicago, which is unusually good at supporting people who come to science in nontraditional ways. I have several of them in my lab. Like me, they’re often the only scientists that their families and community know. Along with other NIH-funded scientists, I’m waiting to see if my R01 grant will be reduced. One threat is the reduction in indirect costs from current negotiated rates to only 15% across the board for NIH grants. (This would be a reduction of $195,000 in my case.) Indirect costs are critical to maintain a building full of science labs (not inexpensive!) and staff it with people who manage core equipment, building infrastructure, housekeeping, hazardous waste disposal, regulatory compliance, and other aspects of administration. I have incredible support here at Loyola, and it costs money to employ those professionals and keep this building running. That means I don’t have to think about many of those things—I can focus on mentoring students and conducting research. A second threat is that my grant could be renewed with a lower amount overall for its fourth year this May. Multi-year NIH grants have yearly renewal. Depending on factors like congressional budgets, or the new unpredictable factors in the current administration, it could come late, and/or it could come in with a reduction. Or it could be cancelled altogether as a bargaining chip for controlling universities or de-prioritizing certain funding topics, as we’ve seen at Columbia and elsewhere. The only way to take risks and make scientific breakthroughs is with guaranteed support and stability for the people doing the work. Right now, we don’t have that. It hurts to talk to students graduating right now about their job searches. I want to be the mentor with answers, but I don’t have them, nor do any of us pursuing science careers in the USA right now.

- Abby Kroken
Kelton Minor's avatar

There are days in life that shake you. I’m shattered 💔 to share that I just found out that the US government has terminated my 2024 National Institutes of Health (NIH) Director’s Early Independence Award (~$2 million) as a part of the new administration’s punitive actions targeting Columbia University, its faculty and students. As a proud American born and raised in the “land of the free” I never thought that my scientific research would be cancelled by my very own government. My grant is being terminated even after congress already awarded the funds. This action not only jeopardizes my innovative research program and long-promised promotion to assistant professor at Columbia University, it also robs the public and future generations of the scientific knowledge and broader benefits to come. My story is one of hundreds wrapped up in the initial cancellation of $400 million in federal funding targeting Columbia University, a shocking $250 million of which is NIH funding. Chilling. But this and other federal actions against Columbia University risk far more, raising urgent questions that we ALL must grapple with. If the government claims to be punishing Columbia University for allowing what it describes as “illegal protests” and repeatedly failing to protect students from “anti-Semitic harassment on campus” (quoted text: shorturl.at/QSWH6), then why is the government disproportionately terminating medical, public health, and environmental health funding? The US just announced that 60 other universities are being targeted for similar investigations... How is the government (and possibly DOGE) targeting which grants to cut (what specific AI prompts + keywords are they using), and where is the transparency? Decisions for which grants to cut didn’t come from NIH program officers who manage the grants, but from higher up. Are certain scientific topics in the public interest now off limit for any federal funding, even if that funding was already appropriated by congress? It would certainly appear so from these initial cuts at Columbia University. Democracy dies in darkness. These answers need to be brought to light. If history is a guide, science will continue, but I fear the impact these policies will have on the top US scientific talent. Early career scientists like me are having the ladder pulled out from under us at a critical moment. Long held as a bastion of academic freedom and a premier supporter of science, the US has been the top destination for the world’s best scientists, providing immense health, economic, and societal benefits that have altered the course of history and saved countless lives in the US and globally. Whether that remains to be the case largely depends on what happens next, and where scientists go. Please share this story. Talk about it with your colleagues, friends, and family. Spread the word, and don’t let what’s happening die in darkness. When we shut the eyes of science, we lose more than we know.

- Kelton Minor
Astor Perkins's avatar

‘My career is over’: Columbia University scientists hit hard by Trump team’s cuts On Tuesday morning this week, PhD student Daniella Fodera woke up at 7 a.m. to a call from the head of her research laboratory in Columbia University’s Department of Biomedical Engineering, delivering devastating news. Her F31 fellowship, a research training grant that provides the majority of her annual income, had been terminated. “It was traumatic,” Fodera says. “I immediately just broke into tears.” Fodera, who studies fibroids in the uterus — non-cancerous growths that affect 70%–80% of women by the age of 50, and can cause severe pain and infertility — is just one of numerous scientists affected by the decision of US President Donald Trump’s administration to cancel US$400 million in federal grants and contracts to Columbia, located in New York City. Announced on 7 March, the move, Trump’s team said, stemmed from the university’s “continued inaction in the face of persistent harassment of Jewish students” and that more cancellations “are expected to follow”. Most of those affected are researchers and students whose grants and fellowships come from the US National Institutes of Health, the world’s largest funder of biomedical research. The agency announced on Monday that it was terminating more than $250 million in funding — including more than 400 research grants — to Columbia. Several university lab leaders, PhD students and postdocs have expressed concern to Nature about their future in science and their ability to support themselves and their families. Although a complete list of cancelled grants hasn’t been released, Nature’s reporting suggests that early-career scientists receiving NIH training grants such as F30, F31, R25 and T32 fellowships are heavily affected. Sources inside the NIH tell Nature that the lists of cancelled grants come from the agency’s Office of Extramural Research, which is in turn receiving them from the NIH’s parent agency, the US Department of Health and Human Services, in coordination with the US Department of Government Efficiency. Action on the lists is required immediately, often within the hour. A spokesperson at Columbia told Nature that the university is in the process of reviewing termination notices and “cannot confirm how many grant cancellations have been received from federal agencies since March 7”. Still, she wrote, Columbia “pledges to work with the federal government to restore Columbia’s federal funding”. lnkd.in/g35xdW-n

- Astor Perkins
Bob Fabien "BZ" Zinga (版主) 🇺🇸🇺🇦's avatar

Daniella Fodera, a doctoral student at Columbia University, received an unexpected early morning call from her research adviser informing her that her #fellowship had been abruptly terminated. The fellowship, which she had spent a year securing through a rigorous application and review process, was essential in funding her research on the #biomechanics of uterine fibroids—tissue growths that can cause severe pain, heavy bleeding, and infertility. Uterine fibroids affect up to 77% of women as they age, yet they remain significantly underresearched. Fodera was devastated by the news, breaking down in tears while speaking with her parents. She voiced deep concerns not only for her own academic future but also for the broader implications on women’s #healthresearch. She feared that the cancellation of funding for multiple researchers like herself would further stall progress in a field that has already suffered from decades of neglect. Her fellowship was a casualty of new federal funding cuts imposed at Columbia University, which was among several institutions targeted by the Trump administration. Researchers say federal agencies have been instructed not to approve grants that include the words “#women,” “#trans,” or “#diversity.” In addition to reducing research funding, the administration was also cutting jobs at the The National Institutes of Health (#NIH), the primary federal agency responsible for overseeing public health research. These cuts threatened to significantly slow scientific advancements in critical health areas, particularly those affecting #women, raising alarms about the long-term consequences for #medicalresearch and #publichealth initiatives. 👉 If you like what you are reading, please follow me on LinkedIn: lnkd.in/gcVzvEv7 #Diversity #Equity #Inclusion #Women #HealthResearch #GenderEquity Source: lnkd.in/gp6D-R2Y

- Bob Fabien "BZ" Zinga (版主) 🇺🇸🇺🇦
Brittany Charlton's avatar

Grateful to Katie Wu at The Atlantic for being responsive, thorough, and reflective when I asked if she'd tackle this story. In the hours since publication, however, our work has entirely changed... I originally felt compelled to speak out in a climate where fear stifles many voices. As Katie quoted me saying, none of my grants had been terminated at the time of our last interview. While I had a lot to lose, this story had to come to light—not just for the LGBTQ community, but for all Americans. However, I just received a "termination" letter for one of my large-scale NIH grants. Our research is now halted on revealing how discriminatory laws (e.g., 'Don't Say Gay' bills) lead to depression and suicide among LGBTQ teens. This "termination" letter is unprecedented as NIH grants are reviewed and approved in a highly competitive grant process and rarely are forced to stop. But now our grants are being terminated solely because the work is "in conflict" with various executive orders (e.g., “gender ideology,” DEI). LGBTQ health is not an obscure, fringe, or ideological issue. The latest data show that 1 in 10 Americans identify as LGBTQ and the number is twice as high among young people. We’re not trying to advance any radical ideology. We’re scientists, trying to keep people healthy. This should be a goal that everyone can get behind. And it is frightening to see our research being cancelled without cause. Our science shows political rhetoric targeting the LGBTQ community causes real, painful harms. Talk isn’t “just” talk — it causes devastating health impacts. Having our NIH-funded research halted is a double whammy. It’s not just that the administration is shutting down research designed to improve health. They are also harming health with rhetoric that seeks to erase our entire community from existence. We desperately need foundations and individual philanthropists to sustain our research. Many of our studies have been ongoing for decades and are in jeopardy of being permanently destroyed. And at the same time, while we need philanthropy, it cannot entirely fill the gap. The NIH is the world's largest funder of biomedical research; it must continue to fund a broad range of rigorous science to improve health and well-being for every member of our society. Read the full piece 👇 lnkd.in/ec3Yb2AU

- Brittany Charlton
Carrie Wolinetz's avatar

The U.S. Department of Health and Human Services (HHS) has publicly posted a list of awards that have been terminated: lnkd.in/eu3zNmVE (Found linked on this page: taggs.hhs.gov/) In addition to recommending the excellent article in The Atlantic by Katherine J. Wu on the havoc wreaked by this unprecedented and abrupt cessation of funding (lnkd.in/ewKSZ-Fx), I think everyone should take a moment to reflect on what our country is choosing to end (and note this is an incomplete list, so the damage is far greater). Grants on #Alzheimers Disease. Awards to understand why men and women have different responses to therapy for #kidney disease. Training programs for young scientists. A center award to accelerate translational research so that treatments get to patients faster. An award focused on education to prevent zoonotic diseases, like bird flu. This is the ending medical research in more than two dozen states, red and blue: Alabama; Arizona; California; Colorado; Connecticut; DC; Florida; Georgia; Illinois; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Montana; Nebraska; Nevada; New York; North Carolina; Ohio; Pennsylvania; Rhode Island; South Carolina; Tennessee; Texas; Vermont; and Washington. For those states, this means people are losing jobs, patients are losing the opportunity to participate in clinical studies near their homes, and the economic activity associated with research funded by The National Institutes of Health has been lost. Priorities change with Administrations. There are ways to reprogram money to align with new priorities, instead of terminating. Finding treatments to terminal diseases should be a higher priority than accelerating processes to terminal awards.

- Carrie Wolinetz
Danielle B.'s avatar

My favorite thing for today, the day after many NIH study sections were abruptly cancelled: the study of public administration, specifically, the work of Dr. Don Kettl, who wrote my favorite book, The Transformation of Governance. Dr. Kettl's writing has a spirit of creativity, practicality, and bridge building that we desperately need right now. Public administration and management is a field of study, with scientists who research what works and what doesn't. You don't just throw ideas at the ceiling and see what sticks. There is an evidence base for best practices. There are reasons that things are set up the way that they are, with researchers (and public administrators) constantly trying to improve these systems for maximum public benefit. I often joke that I got my doctorate in public administration because you need a PhD in bureaucracy to raise a child with disabilities. It seems that we also need a PhD in bureaucracy to do science. Yesterday was a sad and difficult day with the chaos and confusion around the grant reviews, but as someone who has watched a child have seizures nearly every day for 14+ years, I can tell you that we are tougher than we know. In the words of the great Florynce Kennedy (look her up): "Don't agonize, organize!" We can't spiral. We must dust ourselves off and keep going. Patient advocates are very good at organizing and telling our stories, especially the stories about the need for research into our diseases. It is once again time for us to lead. It is not fair but I don't have to tell you that life is unfair. In the coming days I will post about ways to support our colleagues in government and academic research, so that we can continue our good, DIVERSE, EQUITABLE, AND INCLUSIVE work together. I welcome the advice of experts in my network and hope to create a positive place for brainstorming and information. The first thing we can do is simple: check in with our colleagues and let them know that we support them.

- Danielle B.
Abby Kroken's avatar

I’m grateful that the WLC magazine included an article about me, highlighting the 1.9M NIH grant I received. However, I’m uncertain if that figure will remain accurate, and what current changes to science funding mean for me as a newer independent scientist, and for the futures of the trainees in my lab. I have nothing but gratitude for the education, support, and encouragement I got from WLC, especially as a first generation college student. I was still figuring out what sorts of things excited me the most, and which career options might let me do more of those activities. I would have never guessed that being a professor and a scientist was in my future, but my mentors showed me what was possible at each step of my training—at WLC, MCW, and UC Berkeley. As a result, I’m passionate about places that support first gen students and scientists, and every day I’m grateful that I landed at Loyola University Chicago, which is unusually good at supporting people who come to science in nontraditional ways. I have several of them in my lab. Like me, they’re often the only scientists that their families and community know. Along with other NIH-funded scientists, I’m waiting to see if my R01 grant will be reduced. One threat is the reduction in indirect costs from current negotiated rates to only 15% across the board for NIH grants. (This would be a reduction of $195,000 in my case.) Indirect costs are critical to maintain a building full of science labs (not inexpensive!) and staff it with people who manage core equipment, building infrastructure, housekeeping, hazardous waste disposal, regulatory compliance, and other aspects of administration. I have incredible support here at Loyola, and it costs money to employ those professionals and keep this building running. That means I don’t have to think about many of those things—I can focus on mentoring students and conducting research. A second threat is that my grant could be renewed with a lower amount overall for its fourth year this May. Multi-year NIH grants have yearly renewal. Depending on factors like congressional budgets, or the new unpredictable factors in the current administration, it could come late, and/or it could come in with a reduction. Or it could be cancelled altogether as a bargaining chip for controlling universities or de-prioritizing certain funding topics, as we’ve seen at Columbia and elsewhere. The only way to take risks and make scientific breakthroughs is with guaranteed support and stability for the people doing the work. Right now, we don’t have that. It hurts to talk to students graduating right now about their job searches. I want to be the mentor with answers, but I don’t have them, nor do any of us pursuing science careers in the USA right now.

- Abby Kroken
Kelton Minor's avatar

There are days in life that shake you. I’m shattered 💔 to share that I just found out that the US government has terminated my 2024 National Institutes of Health (NIH) Director’s Early Independence Award (~$2 million) as a part of the new administration’s punitive actions targeting Columbia University, its faculty and students. As a proud American born and raised in the “land of the free” I never thought that my scientific research would be cancelled by my very own government. My grant is being terminated even after congress already awarded the funds. This action not only jeopardizes my innovative research program and long-promised promotion to assistant professor at Columbia University, it also robs the public and future generations of the scientific knowledge and broader benefits to come. My story is one of hundreds wrapped up in the initial cancellation of $400 million in federal funding targeting Columbia University, a shocking $250 million of which is NIH funding. Chilling. But this and other federal actions against Columbia University risk far more, raising urgent questions that we ALL must grapple with. If the government claims to be punishing Columbia University for allowing what it describes as “illegal protests” and repeatedly failing to protect students from “anti-Semitic harassment on campus” (quoted text: shorturl.at/QSWH6), then why is the government disproportionately terminating medical, public health, and environmental health funding? The US just announced that 60 other universities are being targeted for similar investigations... How is the government (and possibly DOGE) targeting which grants to cut (what specific AI prompts + keywords are they using), and where is the transparency? Decisions for which grants to cut didn’t come from NIH program officers who manage the grants, but from higher up. Are certain scientific topics in the public interest now off limit for any federal funding, even if that funding was already appropriated by congress? It would certainly appear so from these initial cuts at Columbia University. Democracy dies in darkness. These answers need to be brought to light. If history is a guide, science will continue, but I fear the impact these policies will have on the top US scientific talent. Early career scientists like me are having the ladder pulled out from under us at a critical moment. Long held as a bastion of academic freedom and a premier supporter of science, the US has been the top destination for the world’s best scientists, providing immense health, economic, and societal benefits that have altered the course of history and saved countless lives in the US and globally. Whether that remains to be the case largely depends on what happens next, and where scientists go. Please share this story. Talk about it with your colleagues, friends, and family. Spread the word, and don’t let what’s happening die in darkness. When we shut the eyes of science, we lose more than we know.

- Kelton Minor
Astor Perkins's avatar

‘My career is over’: Columbia University scientists hit hard by Trump team’s cuts On Tuesday morning this week, PhD student Daniella Fodera woke up at 7 a.m. to a call from the head of her research laboratory in Columbia University’s Department of Biomedical Engineering, delivering devastating news. Her F31 fellowship, a research training grant that provides the majority of her annual income, had been terminated. “It was traumatic,” Fodera says. “I immediately just broke into tears.” Fodera, who studies fibroids in the uterus — non-cancerous growths that affect 70%–80% of women by the age of 50, and can cause severe pain and infertility — is just one of numerous scientists affected by the decision of US President Donald Trump’s administration to cancel US$400 million in federal grants and contracts to Columbia, located in New York City. Announced on 7 March, the move, Trump’s team said, stemmed from the university’s “continued inaction in the face of persistent harassment of Jewish students” and that more cancellations “are expected to follow”. Most of those affected are researchers and students whose grants and fellowships come from the US National Institutes of Health, the world’s largest funder of biomedical research. The agency announced on Monday that it was terminating more than $250 million in funding — including more than 400 research grants — to Columbia. Several university lab leaders, PhD students and postdocs have expressed concern to Nature about their future in science and their ability to support themselves and their families. Although a complete list of cancelled grants hasn’t been released, Nature’s reporting suggests that early-career scientists receiving NIH training grants such as F30, F31, R25 and T32 fellowships are heavily affected. Sources inside the NIH tell Nature that the lists of cancelled grants come from the agency’s Office of Extramural Research, which is in turn receiving them from the NIH’s parent agency, the US Department of Health and Human Services, in coordination with the US Department of Government Efficiency. Action on the lists is required immediately, often within the hour. A spokesperson at Columbia told Nature that the university is in the process of reviewing termination notices and “cannot confirm how many grant cancellations have been received from federal agencies since March 7”. Still, she wrote, Columbia “pledges to work with the federal government to restore Columbia’s federal funding”. lnkd.in/g35xdW-n

- Astor Perkins
Bob Fabien "BZ" Zinga (版主) 🇺🇸🇺🇦's avatar

Daniella Fodera, a doctoral student at Columbia University, received an unexpected early morning call from her research adviser informing her that her #fellowship had been abruptly terminated. The fellowship, which she had spent a year securing through a rigorous application and review process, was essential in funding her research on the #biomechanics of uterine fibroids—tissue growths that can cause severe pain, heavy bleeding, and infertility. Uterine fibroids affect up to 77% of women as they age, yet they remain significantly underresearched. Fodera was devastated by the news, breaking down in tears while speaking with her parents. She voiced deep concerns not only for her own academic future but also for the broader implications on women’s #healthresearch. She feared that the cancellation of funding for multiple researchers like herself would further stall progress in a field that has already suffered from decades of neglect. Her fellowship was a casualty of new federal funding cuts imposed at Columbia University, which was among several institutions targeted by the Trump administration. Researchers say federal agencies have been instructed not to approve grants that include the words “#women,” “#trans,” or “#diversity.” In addition to reducing research funding, the administration was also cutting jobs at the The National Institutes of Health (#NIH), the primary federal agency responsible for overseeing public health research. These cuts threatened to significantly slow scientific advancements in critical health areas, particularly those affecting #women, raising alarms about the long-term consequences for #medicalresearch and #publichealth initiatives. 👉 If you like what you are reading, please follow me on LinkedIn: lnkd.in/gcVzvEv7 #Diversity #Equity #Inclusion #Women #HealthResearch #GenderEquity Source: lnkd.in/gp6D-R2Y

- Bob Fabien "BZ" Zinga (版主) 🇺🇸🇺🇦